时间标签：数据日期 2026-11-01 · 生成时间 2026-11-01 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31–2026/11/01 ｜ 情报发生日期 2026-11-01
证据级别：摘要级。本条依据 PubMed 结构化摘要与元数据撰写，付费墙全文未获取、未逐节核验，本站未做任何数值推算补全。
研究问题
To summarize the available evidence on the management of cervical cancer in older women across early and advanced disease stages, with particular attention to treatment selection, feasibility, tolerance, and specific clinical situations,…
方法
Data on cervical cancer associated with pelvic organ prolapse are limited to heterogeneous case reports and small retrospective studies.；Age-specific evidence remains limited and largely retrospective, and chronological age alone should not determine access to standard treatment.
核心结论
To summarize the available evidence on the management of cervical cancer in older women across early and advanced disease stages, with particular attention to treatment selection, feasibility, tolerance, and specific clinical situations, including cervical…；Studies addressing surgery, radiotherapy, concurrent chemoradiotherapy, brachytherapy, para-aortic lymphadenectomy, cervical cancer associated with pelvic organ prolapse, and pre-treatment geriatric assessment were considered.；In early-stage disease, radical hysterectomy is feasible in selected fit elderly patients but is associated with increased perioperative morbidity, with advancing age.；In locally advanced cervical cancer, concurrent chemoradiotherapy appears to improve survival compared with radiotherapy alone in selected older patients, but with increased toxicity.
局限
The available evidence does not establish whether surgery or definitive radiotherapy provides superior oncological outcomes in this population.
对本项目的价值
综述级证据，用于快速对齐领域共识与空白：与肿瘤交叉参考：衰老机制在肿瘤治疗抵抗 / 毒性中的双向作用。 ｜ 价值分 0.5/5（★☆☆☆☆）
全文来源
未取到全文 → 本卡为摘要级解读，未核验全文
原文题录
- 英文标题：CERVICAL CANCER IN OLDER WOMEN - A NARRATIVE REVIEW OF AGE-SPECIFIC MANAGEMENT ISSUES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
- 期刊与标识：Journal of gynecology obstetrics and human reproduction · PMID 42956935 · DOI 10.1016/j.jogoh.2026.103317
C 级证据分级：C 级（预印本 / 观点评论，非原始研究）
本文属观点/评论类文献，不是原始研究。其论点依赖于作者对既有证据的梳理与判断，不构成新的实验证据。本站标注 C 级即为此意——阅读时请把它当作「领域内的思考框架」，而非「研究发现」。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」（SOP §4.2 摘要级）撰写，依据期刊公开摘要与 PubMed 元数据；付费墙全文未获取之处已标注「待补全文」，未做任何数值推算补全。